Semler Scientific to Expand Bitcoin Holdings

Reading Time: < 1 minute

Semler Scientific, Inc., a medical device company with notable gross profit margins of 91.55% and a market cap of $329.16 million, has released preliminary financial results for Q1 ending March 31, 2025.

These results indicate an operational loss and a significant decrease in the value of its Bitcoin holdings.

Known for its electromedical and electrotherapeutic devices, the company is finalizing its full financial results.

In a recent Form 8-K filing with the Securities and Exchange Commission, Semler Scientific expects to report revenues between $8.8 million and $8.9 million, following a 17.44% revenue decline over the past year.

The anticipated operational loss is between $1.3 million and $1.5 million, influenced by non-cash stock compensation of approximately $1.5 million, a state sales and use tax accrual of $0.4 million, and legal fees of $0.4 million related to a civil investigative demand from the US Department of Justice.